X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ALGS

Closed

Aligos Therapeutics inc

7.39
+0.18 (+2.50%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 7.21
Day's Range: 6.8242 - 7.42
Send
When Written:
 
0.874
Aligos Therapeutics Inc is a clinical-stage biotechnology company that focuses on developing treatments for viral infections and liver diseases. The company's lead product candidates are designed to target chronic hepatitis B virus (HBV) and COVID-19. Aligos Therapeutics uses a proprietary technology platform to develop small molecule drugs that target specific viral proteins and enzymes. The company is headquartered in South San Francisco, California, and was founded in 2018. Aligos Therapeutics has partnerships with several pharmaceutical companies and research institutions to advance its drug development programs.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X